Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Cytoskeleton / ECM Basal Lamina

Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330)

Price and availability

298 185 ₸

Availability

Order now and get it on Thursday March 04, 2021

Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR18919] to Laminin alpha 5/LAMA5
  • Suitable for: WB
  • Reacts with: Mouse, Rat, Human, Recombinant fragment

You may also be interested in

Product image
Anti-Entactin/NID antibody - BSA and Azide free (Capture) (ab272277)
Product image
Anti-LAMB3 antibody [EPR7524] (ab128864)
Product image
Anti-Collagen IV antibody [rCOL4/4742] - BSA and Azide free (ab273609)
Product image
Anti-LAMB3 antibody [EPR7525] - BSA and Azide free (ab248956)

Overview

  • Product name

    Anti-Laminin alpha 5/LAMA5 antibody [EPR18919]
    See all Laminin alpha 5/LAMA5 primary antibodies
  • Description

    Rabbit monoclonal [EPR18919] to Laminin alpha 5/LAMA5
  • Host species

    Rabbit
  • Specificity

    This antibody reacts weakly with Laminin alpha 3
  • Tested Applications & Species

    Application Species
    WB
    Mouse
    Rat
    Human
    Recombinant fragment
    See all applications and species data
  • Immunogen

    Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • WB: Mouse Laminin alpha 5/LAMA5 and alpha 3 fragment recombinant proteins; Human fetal kidney lysate; A549 whole cell lysate; Mouse P5 fetal kidney and P3 fetal lung lysates; Rat kidney lysate.
  • General notes

     This product was previously labelled as Laminin alpha 5

     

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
  • Storage buffer

    pH: 7.2
    Preservative: 0.01% Sodium azide
    Constituents: 59% PBS, 0.05% BSA, 40% Glycerol (glycerin, glycerine)
  • Concentration information loading...
  • Purity

    Protein A purified
  • Clonality

    Monoclonal
  • Clone number

    EPR18919
  • Isotype

    IgG
  • Research areas

    • Signal Transduction
    • Cytoskeleton / ECM
    • Basal Lamina
    • Neuroscience
    • Cell Adhesion Proteins
    • ECM Proteins

Images

  • Western blot - Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330)
    Western blot - Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330)
    All lanes : Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330) at 1/1000 dilution

    Lane 1 : Mouse Laminin alpha 5/LAMA5 fragment recombinant protein
    Lane 2 : Mouse Laminin alpha 3 fragment recombinant protein

    Lysates/proteins at 0.01 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution

    Predicted band size: 404 kDa



    Blocking/Dilution buffer: 5% NFDM/TBST.

    Exposure time: Lane 1: 15 seconds; Lane 2: 3 minutes.

    Mouse Laminin alpha 5/LAMA5 fragment recombinant protein contains aa46-304 with a His-Tag; Mouse Laminin alpha 3 fragment recombinant protein contains aa43-295 with a His-Tag.

  • Western blot - Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330)
    Western blot - Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330)
    All lanes : Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330) at 1/1000 dilution

    Lane 1 : Human fetal kidney lysate
    Lane 2 : A549 (Human lung carcinoma cell line) whole cell lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution

    Predicted band size: 404 kDa
    Observed band size: 404 kDa


    Exposure time: 3 minutes


    Blocking/Dilution buffer: 5% NFDM/TBST.

    The expression profile observed is consistent with what has been described in the literature (PMID:12559092; PMID:9624186).

  • Western blot - Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330)
    Western blot - Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330)
    All lanes : Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330) at 1/1000 dilution

    Lane 1 : Mouse P5 fetal kidney lysate
    Lane 2 : Mouse P3 fetal lung lysate
    Lane 3 : Mouse liver lysate
    Lane 4 : Rat kidney lysate

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution

    Predicted band size: 404 kDa
    Observed band size: 404 kDa



    Blocking/Dilution buffer: 5% NFDM/TBST.

    Exposure time: Lane 1 and 2: 30 seconds; Lane 3 and 4: 3 minutes.

    The expression profile observed is consistent with what has been described in the literature (PMID:12559092; PMID:9624186).

     Negative control: mouse liver (PMID:7499364).

  • Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330)
    Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] (ab184330)

  •  
  • Anti-Laminin alpha 5/LAMA5 antibody (ab75344)

    Applications:

  •  
  • Product image

    Anti-Laminin alpha 5/LAMA5 antibody [4C7] (ab17107)

    Applications: IHC-P

  •  
  • Product image

    Anti-Laminin alpha 5/LAMA5 antibody [EPR18919] - BSA and Azide free (ab271947)

    Applications: WB

  •  
  • Product image

    Anti-Laminin alpha 5/LAMA5 antibody [CL3118] (ab210957)

    Applications: IHC-P, WB

  •  
  • Product image

    Anti-Laminin alpha 5/LAMA5 antibody (ab238582)

    Applications: IHC-P

  •  
  • Product image

    Anti-Laminin alpha 5/LAMA5 antibody [4B12] (ab77175)

    Applications: ICC/IF

  •  
  • Product image

    Anti-Laminin alpha 5/LAMA5 antibody (ab220399)

    Applications: ICC/IF

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Integrin alpha 2 antibody [EPR17349] (ab181549)

  •  
  • Product image

    Anti-Thiophosphate ester antibody [51-8] (ab133473)

  •  
  • Product image

    Anti-NR2E1/Tailless/TLX antibody [EPR4491] (ab109179)

  •  
  • Product image

    HRP Anti-beta Actin antibody [AC-15] (ab49900)

  •  
  • Product image

    Anti-Cytokeratin 8 antibody [SP102] - BSA and Azide free (ab240986)

  •  
  • Product image

    Anti-BACE1 antibody [EPR19523] - BSA and Azide free (ab238937)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.